| miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer | breast, |
| miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-alpha, CCNJ, and MEGF9. | breast, |
| The dual action of hsa-miR-125b as a tumor suppressor and hsa-miR-22 as an oncomiR contributed to prostate tumorigenesis by modulations in PI3K/AKT and MAPK/ERK signaling pathways. | prostate, |
| MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma | osteosarcoma, |
| miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism | sarcoma, |
| miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma | esophageal, |
| miR-125b-5p functions as a tumor suppressor and regulates breast cancer cell progression through targeting KIAA1522 | breast, |
| MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer | breast, |
| This study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. | None |
| a novel molecular mechanism by which MMP13 is up-regulated in cSCCs and indicate that miR-125b plays a tumor suppressive role in cSCC. | None |
| An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. | prostate, |
| miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. | prostate, |
| MicroRNA miR-125b causes leukemia. | leukemia, |
| miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. | breast, |
| miR-125b can act as an oncogene in B-cell acute lymphoblastic leukemia by targeting ARID3a and mediating its repression. | leukemia, |
| miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. | nasopharyngeal,laryngeal, |
| MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. | colorectal, |
| MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells. | gastric, |
| MicroRNA-27a inhibitors alone or in combination with perifosine suppress the growth of gastric cancer cells. | gastric, |
| MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. | leukemia, |